Frontlight ResearchEarly access
Trial site
Campinas
- 4running trials
- 3closed trials
The trials here
What the 7 trials at this site are about, from their registry records.
- Conditions
- Coronary artery disease3 trials
- Stroke3 trials
- Familial hypercholesterolaemia2 trials
- Chronic myeloid leukaemia1 trial
- Heart failure1 trial
- Sickle cell disease1 trial
- Phase
- Phase 35 trials
- Phase 21 trial
- Phase 41 trial
- Status
- Active, not recruiting3 trials
- Completed3 trials
- Recruiting1 trial
- Lead sponsor
- Novartis Pharmaceuticals7 trials
Running trials
Active, not recruiting
Recruiting
Active, not recruiting
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Sickle cell disease1 recruiting
Closed trials
Completed
Completed
Completed
Treatment-free Remission After Achieving Sustained MR4.5 on Nilotinib (ENESTop)
Site data: ClinicalTrials.govUpdated 17 Nov 2026